Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years’ experience in a national study in New Zealand

To re‐evaluate a national prospective study in New Zealand after 17 years to define whether orchidectomy alone and surveillance for nonseminoma germ cell testicular tumour (NSGCTT) is a sound policy and matches the results achieved by other treatment protocols.

[1]  O. Dahl,et al.  Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer. , 1997, European journal of cancer.

[2]  J. Sawyer,et al.  Secondary acute myelogenous leukemia following safe exposure to etoposide. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Cornbleet,et al.  Follow-up for Stage 1 teratoma surveillance patients. , 1996, European journal of cancer.

[4]  M. Williams,et al.  Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Pont,et al.  Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  H. D. de Bruijn,et al.  Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  V. Harvey,et al.  Late seminomatous relapse of a mixed germ cell tumor of the testis on intensive surveillance. , 1995, The Journal of urology.

[8]  J. Libertino,et al.  Recurrence of a nonseminomatous germ cell tumor 9 years postoperatively: is surveillance alone acceptable? , 1995, The Journal of urology.

[9]  L. Kumar.  Epipodophyllotoxins and secondary leukaemia , 1993, The Lancet.

[10]  V. Harvey,et al.  Results of the surveillance policy of stage I non-seminomatous germ cell testicular tumours. , 1992, British journal of urology.

[11]  A. Horwich,et al.  Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Gospodarowicz,et al.  Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  C. Yang,et al.  Results of adjuvant chemotherapy for low‐stage nonseminomatous germ cell tumors of the testis with vascular invasion , 1988, Cancer.

[14]  L. Freedman,et al.  HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONE , 1987, The Lancet.

[15]  W. Whitmore,et al.  Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors. , 1983, Journal of Urology.

[16]  A. Barrett,et al.  ORCHIDECTOMY ALONE IN TESTICULAR STAGE I NON-SEMINOMATOUS GERM-CELL TUMOURS , 1982, The Lancet.

[17]  V. Schuermans,et al.  IMPAIRED NEUTROPHIL PHAGOCYTOSIS , 1974 .

[18]  D. Skinner,et al.  The surgical management of testis tumors. , 1971, The Journal of urology.

[19]  A. Horwich.  Current issues in the management of clinical stage I testicular teratoma. , 1993, European journal of cancer.

[20]  J. Droz,et al.  Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: a wager on the future? A review. , 1993, European journal of cancer.

[21]  F. Mostofi,et al.  Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  C. Moynihan.  Testicular cancer: the psychosocial problems of patients and their relatives. , 1987, Cancer surveys.